A nationwide shortage of BCG vaccines in the country leaves Kenyan newborns vulnerable to TB, a disease with a high ...

A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...

An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin (BCG) immunotherapy, a vaccine also used ...

Scientists have developed a breakthrough mechanism that makes the intravenous Bacillus Calmette-Guérin (BCG) tuberculosis ...

Hospitals across the country are now facing a shortage of the Bacille Calmette-Guérin (BCG) vaccine, which protects newborns ...

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.

Kenya has completely run out of essential medical supplies—including HIV medicines, testing kits, and vaccines—putting ...

Data from a late-stage study shows that treatment with PFE's PD-1 inhibitor when added to BCG improves outcomes in certain ...

The in-built in protection mechanisms offer a safer and more effective way to combat the deadliest disease of 2024.

A new study published in the Journal of Internal Medicine showed that it may be possible to prevent the formation of ...

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in ...